Approval No: SFDA approval number H20213537
Specification: 1.5mg
Packaging/box: 14 tablets&28 tablets
Production enterprise: Hefei Heyuan Pharmaceutical Co., LTD
Mass stratification: New Category 4 (Consistent overassessment)
Medical insurance: Medical insurance class A
Base anther: National essential drug
Adapt to disease:
Adult essential hypertension